Clinical Trial Update: Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Keyhole limpet hemocyanin with doxorubicin in bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• Keyhole Limpet Hemocyanin (Keyhole limpet hemocyanin)

Snippet

Sponsor: Intracel | Conditions: Bladder Cancer | Phase 3 | Status: COMPLETED